What do all of these cases have in common? Therapeutic success, patient satisfaction and drugs being used off-label for treating conditions they have no official indication for.
We surveyed the Medical Post audience to better understand where and how they get fresh medical information, whether it be a quick update on a new drug indication, or sharing wisdom with peers in-person.
May 30 is World MS Day. I’d like to take the opportunity to discuss the importance of pharmacogenomics in providing complete care for patients with multiple sclerosis.
